The accumulation of oxygen-free radicals and activation of neutrophils are
strongly implicated as important pathophysiological mechanisms mediating my
ocardial ischemia/reperfusion injury. It has been proven that various antio
xidants have cardioprotective effects. Magnolol, an active component extrac
ted from the Chinese medicinal herb Magnolia officinalis, possesses potent
antioxidant and free radical scavenging activities. In this study, the card
ioprotective activity of magnolol was evaluated in an open-chest anesthetiz
ed rat model of myocardial ischemia/reperfusion injury. The results demonst
rated that pretreatment with magnolol (0.2 and 0.5 mug/kg, i.v. bolus) at 1
0 min before 45 min of left coronary artery occlusion, significantly suppre
ssed the incidence of ventricular fibrillation and mortality when compared
with the control group. Magnolol (0.2 and 0.5 mug/kg) also significantly re
duced the total duration of ventricular tachycardia and ventricular fibrill
ation. After 1 h of reperfusion, pretreatment with magnolol (0.2 and 0.5 mu
g/kg) caused a significant reduction in infarct size. In addition, magnolol
(0.2 mug/kg) significantly reduced superoxide anion production and myelope
roxidase activity, an index of neutrophil infiltration in the ischemic myoc
ardium. In addition, pretreatment with magnolol (0.3 and 0.5 mug/kg) suppre
ssed ventricular arrhythmias elicited by reperfusion following 5 min of isc
hemia. In vitro studies of magnolol (5, 20 and 50 muM) significantly suppre
ssed N-formylmethionyl-leucyl-phenylalanine (fMLP; 25 nM)-activated human n
eutrophil migration in a concentration-dependent manner, It is concluded th
at magnolol suppresses ischemia- and reperfusion-induced ventricular arrhyt
hmias and reduces the size of the infarct resulting from ischemia/reperfusi
on injury. This pronounced cardioprotective activity of magnolol may be med
iated by its antioxidant activity and by its capacity for neutrophil inhibi
tion in myocardial ischemia/reperfusion. (C) 2001 Published by Elsevier Sci
ence B.V.